
Research shows stronger but less frequent drug doses could be key
Researchers in the University of Georgia’s Center for Tropical and Emerging Global Diseases have found that a more intensive, less frequent drug regimen with currently available therapeutics could cure the infection that causes Chagas disease, a potentially life-threatening illness affecting up to 300,000 people in the United States.
Trypanosoma cruzi is a single-celled parasitic organism that causes Chagas disease. At least 6 million people are infected by T. cruzi, mostly in South America. Current drug therapies have been ineffective in completely clearing the infection and are associated with severe adverse side effects.
A single dose of benznidazole has been shown to be highly effective in killing more than 90% of parasites. However, after a CTEGD team found some of the parasites enter into a dormancy stage, the researchers hypothesized that an intermittent treatment schedule could be effective.
Current human trials are only looking at giving lower doses over a shorter time period, which is the exact opposite of what we show works.” — Rick Tarleton
“In this system we can see what a single dose of drug does,” said Rick Tarleton, Regents’ Professor in UGA’s department of cellular biology. “Does it make sense to give a drug twice daily when the remaining dormant parasites are insensitive to it?”
The investigators found that giving as little as two-and-a-half times the typical daily dose of benznidazole, once per week for 30 weeks, completely cleared the infection, whereas giving the standard daily dose once a week for a longer period did not.
“Current human trials are only looking at giving lower doses over a shorter time period, which is the exact opposite of what we show works,” said Tarleton.
Since Tarleton’s team worked with a mouse model, how this change in treatment regimen will translate in humans is yet unknown, as are any potential side effects of the higher doses. Adverse reactions already are a problem with current treatments; the hope is that side effects from a less frequent dosage would be more tolerable.
Significant challenge
Assessing the success of treatments in Chagas disease is a significant challenge. Tissue samples from infected organisms might not be representative of the entire organ or animal, since low numbers of persistent, dormant parasites can be difficult to detect. Therefore, Tarleton’s group used light sheet fluorescence microscopy to view intact whole organs from infected mice.
“With light sheet fluorescence microscopy, you have a broad view of potentially any tissue in the mouse that allows for dependable assessment of parasite load and persistence,” said Tarleton. “It gives you an incredible view of the infection.”
Using this technology, they learned something new about the dormant parasites: Some were still susceptible to drug treatment. This provides hope that new drug therapies could be developed to target these parasites.
“Discovery of new drugs should continue,” Tarleton said. “We still need better drugs.”
Co-led by assistant research scientist Juan Bustamante and research professional Fernando Sanchez in Tarleton’s research group, the study’s findings appear in Science Translational Medicine.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Chagas disease
- New drug approvals hit a high note in 2020 but face uncertainty in 2021on January 4, 2021 at 5:35 am
didn't match 2018's record-breaking performance in the new drug approvals department, but it came pretty darn close.
- Chagas Disease Surveillance Activities — Seven States, 2017on December 25, 2020 at 4:00 pm
Chagas disease, a potentially life-threatening disease caused by the protozoan parasite Trypanosoma cruzi, has become a concern in the United States as a result of human emigration from Latin ...
- Scorpion Venom Helps Treat Chagas Diseaseon December 25, 2020 at 12:10 pm
VmCT1, the antimicrobial peptide isolated from the venom of the scorpion Vaejovis mexicanus killed Trypanosoma cruzi, the parasite that causes Chagas disease, said researchers at the Federal ...
- Enhanced scorpion venom molecules can be used to treat Chagas diseaseon December 21, 2020 at 11:53 am
Chagas is considered a neglected disease by the World Health Organization (WHO). It is endemic in several countries, affecting some 8 million people worldwide and killing around 10,000 per year.
- Chagas Diseaseon December 20, 2020 at 4:01 pm
A new study examines local perceptions of Chagas disease in a region where the infectious agent is endemic. The results underline the need to take social and cultural factors into account in ...
Go deeper with Google Headlines on:
Chagas disease
Go deeper with Bing News on:
Light sheet fluorescence microscopy
- New Imaging Method May Prove Powerful Enough To Observe Viruses In Live Cellson January 5, 2021 at 2:32 am
Researchers have developed a microscopy technique that is 6.6 times ... It works by sending a flat sheet of light in a pulse towards the sample and then measuring the phase shift, which is how ...
- Microscopy Technique Increases Image Clarity by Expanding Dynamic Rangeon January 4, 2021 at 6:57 am
A new technique has been developed by optical physics experts to view inside living cells in more detail by employing present microscopy technology and without the need to add fluorescent dyes or ...
- New microscopy technique images live cells with 7 times greater sensitivityon January 4, 2021 at 6:31 am
Since individual cells are almost translucent, microscope ... such as fluorescence imaging. Quantitative phase imaging sends a pulse of a flat sheet of light towards the cell, then measures ...
- See live cells with seven times greater sensitivity using new microscopy techniqueon January 2, 2021 at 9:57 pm
Since individual cells are almost translucent, microscope ... such as fluorescence imaging. Quantitative phase imaging sends a pulse of a flat sheet of light towards the cell, then measures ...
- University of Tokyo makes live cells visible with 7 times greater sensitivityon January 1, 2021 at 8:00 pm
Experts in optical physics have developed a new way to see inside living cells in greater detail using existing microscopy technology and without needing to add stains or fluorescent dyes.Since ...